Since that time, c-Myb high expression has been associated with oncogenic activity and poor prognosis in several human cancers including T-cell leukemia, acute myelogenous leukemia, colorectal tumors, and most recently in adenoid cystic carcinomas [10], [11]. The gene discussed is MYB; the disease is adenoid cystic carcinoma.